Dr.Christopher Milne discusses reasons big pharma investing in orphan drugs – Video

Posted: Published on December 3rd, 2012

This post was added by Dr P. Richardson




Dr.Christopher Milne discusses reasons big pharma investing in orphan drugs
Christopher-Paul Milne, DVM, MPH, JD of the Tufts Center for the Study of Drug Development is a leading researcher of orphan drugs development and is highly knowledgeable on how to best get orphan drugs to market. Dr. Milne recently spoke to Rare Disease Report and in this video, he discussed some of the reasons that large pharmaceutical companies have started to invest some of their resources into developing orphan drugs.From:rarediseasereport2Views:0 0ratingsTime:02:26More inPeople Blogs

See the article here:
Dr.Christopher Milne discusses reasons big pharma investing in orphan drugs - Video

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.